Dive in
We have our own point of view on the people, technologies, and conversations that will shape the future.
Today, Squint revealed an impressive roster of customers that includes Volvo and Siemens, and announced $6 million in seed and pre-seed funding from Sequoia Arc, Menlo Ventures, and Menlo Labs.
While navigating this exciting yet complex landscape may seem daunting for startups, lessons from past tech waves, along with a thoughtful, strategic approach, can help illuminate the path forward.
We stand on the precipice of an extraordinary platform shift catalyzed by groundbreaking advancements in generative artificial intelligence.
Developing an elevator pitch is a powerful exercise for helping entrepreneurs sharpen their thinking around a potential new business idea. Coming up with innovative ideas is a challenge in itself, and founders are often caught spinning their wheels, struggling to bring clarity and focus to their vision.
Genesis Therapeutics is pioneering AI technologies to create medicines for patients with severe and unmet medical needs.
Retail e-commerce is as old as the advent of the web. In the decades that followed, a wave of innovation across supply chain, logistics, advertising, payments, checkout, and storefront tech has vastly improved the consumer e-commerce experience.
OpenAI’s ChatGPT reached 100 million monthly active users just two months after launch, setting the new standard for the fastest-growing consumer application in history. The landmark achievement underscored the strength of generative AI’s pull in consumer markets—surpassing even the breakthroughs of the internet and smartphones.
Pinecone has raised a $100M Series B led by A16Z—with explosive growth justifying their new $750M valuation.
With Adobe’s proposed $20 billion acquisition, Figma’s tale of disruption is a Cinderella story. Unique insights informed the company’s product decisions, allowing it to become the target of a record-setting acquisition.
Nailing your monetization strategy has become more important than ever in today’s weakened macroeconomic climate, and it’s no longer as simple as charging per seat.
Delfi Diagnostics has developed a test that combines ultra-low-cost sequencing and machine learning to detect cancer early.
Recursion is a breakthrough drug discovery company that combines a novel computer vision platform with deep disease biology and chemistry.
Since the advent of the internet, few technological advances have garnered as much attention and enthusiasm as quickly as generative AI.
Congratulations to Jeremy Zhang, Ansel Parikh, and the Finch team on raising their Series B! For Menlo, it’s an exciting milestone, marking the third consecutive round we’ve invested in Finch.
